News & Updates

Show Multimedia Only
Genetically predicted depression linked to multiple gastrointestinal disorders

Genetically predicted depression linked to multiple gastrointestinal disorders

31 May 2023

Genetic predisposition to major depressive disorder has the potential to increase the risk of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), peptic ulcer disease, and nonalcoholic fatty liver disease (NAFLD), according to the results of a Mendelian randomization study.

31 May 2023
First-line TB treatment: Faropenem rivals ethambutol in efficacy, with fewer side effects

First-line TB treatment: Faropenem rivals ethambutol in efficacy, with fewer side effects

31 May 2023 byJairia Dela Cruz

Faropenem, when used in combination with the other standard treatment drugs for the first-line treatment of tuberculosis (TB) infection, appears to be noninferior to ethambutol, with faropenem having the added benefit of lower frequency of adverse events (AEs), according to the results of an open-label study in China.

31 May 2023
Cytokine profile tied to treatment response in eczematous dermatitis

Cytokine profile tied to treatment response in eczematous dermatitis

31 May 2023

The baseline skin cytokine profile of patients with eczematous dermatitis, as determined by RNA in situ hybridization, can help predict response to dupilumab therapy, results of a study have shown.

31 May 2023
Vaccination protects the young against COVID-19

Vaccination protects the young against COVID-19

31 May 2023 byAudrey Abella

COVID-19 remains a global health concern, and children and adolescents are equally affected. In fact, COVID-19 hospitalization rates in children increased during the Omicron era. [MMWR 2022;71:271-278] In children aged 5–11 years who were hospitalized during the predominance of Omicron, nearly 90 percent were unvaccinated. [MMWR 2022;71:574-581]

31 May 2023